Skip to content

FAGRON BELGIUM

Active
Public limited companyfounded 195967 yrs activeVenecoweg 20A, 9810 Nazareth-De Pinte, BelgiumKBO/BCE: BE 0403.767.052
Summary

The annual accounts of FAGRON BELGIUM for fiscal year 2025 show a net loss of 5,311% of the equity at the start of that year. The 2025 annual accounts show equity of €1.67M and a net result of €-1.36M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 23% of 4867 sector peers (fiscal year 2025). The company has been active since 1959 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
47 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability5▲+3
Solvency46▲+21
Growth37=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €75k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity tight (current ratio 1.03 against 0.76 in 2024; short-term debt: 78.6% and cash: 10% of total assets), and 78.8% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 67 years 0 70 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
21.2%
Return on assets
-17.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 4867 sector peers (2025).
NBB · sector comparison
Position among 4867 sector peers
Solvency
better than 23%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
44 d early
2024
46 d late
2023
35 d early
2022
27 d early
2021
41 d early
2020
38 d early
2019
43 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€23.82M▲ 5.2%
2024 · €22.64M
2018: €18.05M 2019: €17.48M 2020: €23.65M 2021: €23.97M 2022: €23.58M 2023: €19.91M 2024: €22.64M
2018 → 2025
EBIT margin
-3.9%▲ 2.5pp
2024 · -6.3%
2018: 15.2% 2019: 10.1% 2020: 9.9% 2021: 4.9% 2022: 0.9% 2023: -8.3% 2024: -6.3%
2018 → 2025
Net result
€-1.36M▲ 28.8%
2024 · €-1.91M
2018: €1.73M 2019: €1.00M 2020: €1.46M 2021: €573k 2022: €-145k 2023: €-2.08M 2024: €-1.91M
2018 → 2025
Working capital
€211k
2024 · €-1.64M
2018: €-340k 2019: €39k 2020: €1.81M 2021: €2.06M 2022: €1.20M 2023: €-394k 2024: €-1.64M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€23.97M-€23.58M▼ 1.6%€19.91M▼ 15.6%€22.64M▲ 13.7%€23.82M▲ 5.2%
Equity€4.16M-€4.02M▼ 3.5%€1.94M▼ 51.8%€26k▼ 98.7%€1.67M▲ 6,418%
Operating result€1.17M-€204k▼ 82.5%€-1.65M€-1.44M▲ 13.2%€-924k▲ 35.6%
Net result€573k-€-145k€-2.08M▼ 1,335%€-1.91M▲ 8.3%€-1.36M▲ 28.8%
Result per fiscal year
Operating resultNet result
€-3.00M€-2.00M€-1.00M€0€1.00MOperating result 2021: €1.17M€1.17MNet result 2021: €573k€573kOperating result 2022: €204k€204kNet result 2022: €-145k€-145kOperating result 2023: €-1.65M€-1.65MNet result 2023: €-2.08M€-2.08MOperating result 2024: €-1.44M€-1.44MNet result 2024: €-1.91M€-1.91MOperating result 2025: €-924k€-924kNet result 2025: €-1.36M€-1.36M20212022202320242025€-3M€-2M€-1M€0Operating result 2023: €-1.65M€-1.7MNet result 2023: €-2.08M€-2.1MOperating result 2024: €-1.44M€-1.4MNet result 2024: €-1.91M€-1.9MOperating result 2025: €-924k€-924kNet result 2025: €-1.36M€-1.4M202320242025
The operating result stays negative: a loss of €924k in 2025 against €1.44M in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €7.86M
Fixed assets €1.47M ▼ 13.0%
Current assets €6.39M ▲ 22.6%
Equity and liabilities €7.86M
Equity €1.67M ▲ 6,418%
Debt €6.19M ▼ 10.0%
Debt's share of the balance-sheet total falls from 99.6% to 78.8%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-323k▲
2024 · €-749k
Cash flow
€-759k▲
2024 · €-1.22M
Current ratio
1.03▲
2024 · 0.76
Quick ratio
0.29▲
2024 · 0.23
Debt to equity
3.71
ROE
-81.5%
ROA
-17.3%▲
2024 · -27.7%
Interest coverage
-1.89▲
2024 · -4.28
Debt ≤ 1 year
€6.18M▼
2024 · €6.85M
Income taxes
€3k▼
2024 · €17k
Staff costs
€5.32M▲
2024 · €5.24M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 75 lines
Balance sheet Code20242025
Assets
Total assets20/58€6.90M€7.86M▲
Fixed assets21/28€1.69M€1.47M▼
Intangible fixed assets21€1.02M€665k▼
Tangible fixed assets22/27€668k€798k▲
Land and buildings22€61k€327k▲
Plant, machinery and equipment23€282k€202k▼
Furniture and vehicles24€103k€71k▼
Other tangible fixed assets26€220k€129k▼
Assets under construction and advance payments27€2k€70k▲
Financial fixed assets28€4k€4k=
Other financial fixed assets284/8€4k€4k=
Amounts receivable and cash guarantees285/8€4k€4k=
Current assets29/58€5.21M€6.39M▲
Stocks and contracts in progress3€3.64M€4.60M▲
Stocks30/36€3.64M€4.60M▲
Goods purchased for resale34€3.64M€4.60M▲
Amounts receivable within one year40/41€967k€971k▲
Trade receivables40€967k€969k▲
Other amounts receivable41-€2k
Cash at bank and in hand54/58€588k€787k▲
Deferred charges and accrued income490/1€17k€31k▲
Equity and liabilities
Total equity and liabilities10/49€6.90M€7.86M▲
Equity10/15€26k€1.67M▲
Contributions10/11€300k€3.30M▲
Capital10€300k€3.30M▲
Issued capital100€300k€3.30M▲
Reserves13€30k€30k=
Non-distributable reserves130/1€30k€30k=
Legal reserve130€30k€30k=
Profit (loss) carried forward14€-305k€-1.66M▼
Amounts payable17/49€6.87M€6.19M▼
Amounts payable within one year42/48€6.85M€6.18M▼
Trade debts44€5.50M€4.40M▼
Suppliers440/4€5.50M€4.40M▼
Advances received on contracts in progress46€2k€2k=
Taxes, remuneration and social security45€1.25M€1.78M▲
Taxes450/3€514k€841k▲
Remuneration and social security454/9€732k€940k▲
Other amounts payable47/48€98k-
Accrued charges and deferred income492/3€26k€10k▼
Income statement Code20242025
Operating income70/76A€24.80M€26.01M▲
Turnover70€22.64M€23.82M▲
Own construction capitalised72€2k€50k▲
Other operating income74€1.71M€2.14M▲
Non-recurring operating income76A€445k-
Operating charges60/66A€26.24M€26.94M▲
Goods for resale, raw materials and consumables60€13.84M€14.55M▲
Purchases600/8€13.67M€15.23M▲
Change in stocks: decrease (increase)609€167k€-684k▼
Services and other goods61€6.25M€6.71M▲
Remuneration, social security and pensions62€5.24M€5.32M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€686k€601k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€102k€-278k▼
Other operating charges640/8€124k€34k▼
Operating profit (loss)9901€-1.44M€-924k▲
Financial income75/76B€591€14k▲
Recurring financial income75€591€14k▲
Income from current assets751-€868
Other financial income752/9€591€13k▲
Financial charges65/66B€459k€446k▼
Recurring financial charges65€459k€446k▼
Debt charges650€175k€171k▼
Other financial charges652/9€284k€276k▼
Profit (loss) for the period before taxes9903€-1.89M€-1.36M▲
Income taxes67/77€17k€3k▼
Taxes670/3€17k€13k▼
Tax adjustments and reversals of tax provisions77-€9k
Profit (loss) for the period9904€-1.91M€-1.36M▲
Transfer from tax-exempt reserves789€1k-
Profit (loss) for the period to be appropriated9905€-1.91M€-1.36M▲
Appropriation of the result
Profit (loss) to be appropriated9906€-1.91M€-1.66M▲
Profit (loss) brought forward from the previous period14P-€-305k
Transfer from equity791/2€1.60M€2k▼
From reserves792€1.60M€2k▼
Social balance
Average headcount (FTE)908755.057.1▲

The notes to these accounts (63 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
17-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
02-01
State Gazette act Capital & shares
Capital increase · Bank account · Capital8 facts ▸
  • General meeting, 16-12-2025
  • Capital increase, €3.000.000
  • Bank account, BNP Paribas Fortis
  • Capital, €3.300.471,74
  • Statutes amendment
  • Power of attorney, Bestuursorgaan
  • Power of attorney, Stijn RAES
  • Bank attestation, 15-12-2025
2025
31-12
Financial Equity above €1MEq €1.67M ▲6,418%
Equity rises from €26k to €1.67M.
31-12
State Gazette act Appointments: PwC Bedrijfsrevisoren BV (statutory auditor) and Lien Winne BV (statutory auditor)
Permanent representative: Lien Winne · Mandate compensation · Power of attorney6 facts ▸
  • General meeting, 06-10-2025
  • Auditor appointment, PwC Bedrijfsrevisoren BV (statutory auditor)
  • Director appointment, Lien Winne BV (statutory auditor)
  • Permanent representative, Lien Winne
  • Mandate compensation, PwC Bedrijfsrevisoren BV
  • Power of attorney, Franck Cléty
15-09
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 46 days late
2024
26-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Weakest financial yearnet €-2.08M
Net result drops to €-2.08M, the lowest in the series; recovery starts the following year.
30-11
State Gazette act Reappointments: DE JONG Cornelia, PADILLA PAPACEIT Rafael and HUMALIX
Permanent representative: CAVEYE Celine · Statutes amendment · Capital8 facts ▸
  • General meeting, 27-10-2023
  • Statutes amendment
  • Capital, €300.471,74
  • Director reappointment, DE JONG Cornelia (director)
  • Director reappointment, PADILLA PAPACEIT Rafael (director)
  • Director reappointment, HUMALIX (day-to-day manager)
  • Permanent representative, CAVEYE Celine
  • Power of attorney, HUMALIX
04-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
22-12
State Gazette act Appointment: Deloitte Bedrijfsrevisoren CVBA (statutory auditor)
Permanent representative: Ine Nuyts · Approval · Director discharge8 facts ▸
  • General meeting, 16-06-2022
  • Approval, jaarrekening, 31-12-2021
  • Director discharge, FAGRON BELGIUM
  • Director discharge, FAGRON BELGIUM
  • Director discharge, FAGRON BELGIUM
  • Auditor appointment, Deloitte Bedrijfsrevisoren CVBA (statutory auditor)
  • Permanent representative, Ine Nuyts
  • Power of attorney, William Van Lancker
20-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
23-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
Show earlier events
21-05
State Gazette act Resignation: Hernando Acosta (day-to-day manager)
Director discharge2 facts ▸
  • Director resignation, Hernando Acosta (day-to-day manager)
  • Director discharge, Hernando Acosta
2020
01-12
State Gazette act Resignation: Davy De Vlieger (day-to-day manager)
Appointment: Hernando Acosta (day-to-day manager) · Director discharge4 facts ▸
  • Board meeting
  • Director resignation, Davy De Vlieger (day-to-day manager)
  • Director discharge, Davy De Vlieger
  • Director appointment, Hernando Acosta (day-to-day manager)
16-11
State Gazette act Resignations & appointments
Power of attorney3 facts ▸
  • Board meeting, 28-10-2020
  • Power of attorney, Johan Verlinden
  • Power of attorney, Lars Gundlach
18-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
08-11
State Gazette act Appointment: Peter De Sutter (day-to-day manager)
2 facts ▸
  • Board meeting, 01-09-2019
  • Director appointment, Peter De Sutter (day-to-day manager)
04-10
State Gazette act Appointment: Deloitte Bedrijfsrevisoren CVBA (statutory auditor)
Permanent representative: Ine Nuyts3 facts ▸
  • General meeting, 17-06-2019
  • Auditor appointment, Deloitte Bedrijfsrevisoren CVBA (statutory auditor)
  • Permanent representative, Ine Nuyts
18-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
05-06
State Gazette act Resignation: Jumoo bvba (day-to-day manager)
Appointment: Humalix bvba (day-to-day manager) · Permanent representatives: Céline Caveye and Daan Vermeulen · Director discharge7 facts ▸
  • Board meeting, 25-03-2019
  • Director resignation, Jumoo bvba (day-to-day manager)
  • Director discharge, Jumoo bvba
  • Director appointment, Humalix bvba (day-to-day manager)
  • Permanent representative, Céline Caveye
  • Permanent representative, Daan Vermeulen
  • Financial limit, 100000 EUR
2018
26-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
08-02
State Gazette act Resignation: Johannes Stols (director)
Appointments: Rafael Padilla (director) and Cornelia de Jong (managing director) · Mandate compensation6 facts ▸
  • General meeting, 04-12-2017
  • Director resignation, Johannes Stols (director)
  • Director appointment, Rafael Padilla (director)
  • Mandate compensation, Rafael Padilla
  • Board meeting, 04-12-2017
  • Director appointment, Cornelia de Jong (managing director)
2017
04-12
State Gazette act Capital & shares · Miscellaneous
General meeting1 fact ▸
  • General meeting, 25-10-2017
15-09
State Gazette act Resignation: Kalman Petro (day-to-day manager)
Appointment: Jumoo bvba (day-to-day manager) · Permanent representative: Daan Vermeulen · Mandate compensation6 facts ▸
  • General meeting, 28-08-2017
  • Director resignation, Kalman Petro (day-to-day manager)
  • Director appointment, Jumoo bvba (day-to-day manager)
  • Permanent representative, Daan Vermeulen
  • Mandate compensation, Jumoo bvba
  • Mandate limit, 100000 EUR
20-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
12-06
State Gazette act Resignations: Christophe Bouvry (day-to-day manager) and Rony Lebotte (day-to-day manager)
Appointments: Kalman Petro (day-to-day manager) and Davy de Vlieger (day-to-day manager) · Mandate compensation · Binding authority9 facts ▸
  • Board meeting, 31-03-2017
  • Director resignation, Christophe Bouvry (day-to-day manager)
  • Director resignation, Rony Lebotte (day-to-day manager)
  • Director appointment, Kalman Petro (day-to-day manager)
  • Director appointment, Davy de Vlieger (day-to-day manager)
  • Mandate compensation, Kalman Petro
  • Mandate compensation, Davy de Vlieger
  • Binding authority, 500000 EUR
  • Binding authority, 100000 EUR
30-05
State Gazette act Resignation: Jan Peeters NV (director)
Appointment: Corrielia de Jong (director) · Mandate compensation4 facts ▸
  • General meeting, 30-12-2016
  • Director resignation, Jan Peeters NV (director)
  • Director appointment, Corrielia de Jong (director)
  • Mandate compensation, Corrielia de Jong
26-04
State Gazette act Appointment: BCVBA PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Peter Van den Eynde3 facts ▸
  • General meeting, 30-06-2016
  • Auditor appointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Peter Van den Eynde
2016
15-06
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 30-05-2016
10-05
State Gazette act Permanent representative: Jan Peeters
Registered-office move3 facts ▸
  • Board meeting, 29-02-2016
  • Registered-office move, Venecoweg 20A, 9810 Nazareth
  • Permanent representative, Jan Peeters
23-03
State Gazette act Resignation: Gerardus van Jeveren (director and managing director)
Appointment: Johannes Stols (director)5 facts ▸
  • General meeting, 12-12-2015
  • Board meeting, 12-12-2015
  • Director resignation, Gerardus van Jeveren (director and managing director)
  • Director appointment, Johannes Stols (director)
  • Director appointment, Johannes Stols (managing director)
2015
05-02
State Gazette act Resignations & appointments
Name change · Statutes amendment · Power of attorney4 facts ▸
  • General meeting, 12-12-2014
  • Name change, FAGRON BELGIUM
  • Statutes amendment
  • Power of attorney, Johan VERLINDEN
04-02
State Gazette act Miscellaneous
Change of control2 facts ▸
  • General meeting, 10-12-2014
  • Change of control, Wijziging van controle
2014
21-05
State Gazette act Capital & shares
Change of control2 facts ▸
  • General meeting, 11-04-2014
  • Change of control, Wijziging van controle
04-04
State Gazette act Reappointment: BCVBA PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: BVBA Peter Van den Eynde · Mandate compensation4 facts ▸
  • General meeting, 18-06-2013
  • Director reappointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, BVBA Peter Van den Eynde
  • Mandate compensation, BCVBA PwC Bedrijfsrevisoren
05-03
State Gazette act Resignation: Romani Management BVBA (day-to-day manager)
Appointments: Christophe Bouvry (day-to-day manager) and Rony Lebotte (day-to-day manager) · Director discharge · Mandate limit7 facts ▸
  • Board meeting
  • Director resignation, Romani Management BVBA (day-to-day manager)
  • Director discharge, Romani Management BVBA
  • Director appointment, Christophe Bouvry (day-to-day manager)
  • Director appointment, Rony Lebotte (day-to-day manager)
  • Mandate limit, maximaal 1.000.000 EUR
  • Mandate limit, maximaal 1.000.000 EUR
06-02
State Gazette act Reappointments: Jan Peeters NV (director) and Gerardus Van Jeveren (director)
Permanent representative: Jan Peeters · Appointment: Gerardus Van Jeveren (managing director)6 facts ▸
  • General meeting, 18-06-2013
  • Director reappointment, Jan Peeters NV (director)
  • Director reappointment, Gerardus Van Jeveren (director)
  • Permanent representative, Jan Peeters
  • Board meeting, 18-06-2013
  • Director appointment, Gerardus Van Jeveren (managing director)
06-02
State Gazette act Reappointments: Jan Peeters NV (director) and Gerardus Van Jeveren (director)
Permanent representative: Jan Peeters · Mandate expiry5 facts ▸
  • General meeting, 18-06-2013
  • Director reappointment, Jan Peeters NV (director)
  • Director reappointment, Gerardus Van Jeveren (director)
  • Permanent representative, Jan Peeters
  • Mandate expiry, na de algemene vergadering der aandeelhouders die de jaarrekening per 31 december 2018 dient goed te keuren
2013
29-04
State Gazette act Capital & shares · Purpose · Restructuring
Merger · Purpose change · Statutes amendment5 facts ▸
  • General meeting, 28-03-2013
  • Merger, absorption, 31-12-2012
  • Purpose change, De vennootschap heeft tot doel : De handel, de import en export van chemische, pharmaceutische, parapharmaceutische, phytopharmaceutische producten, pharmaceuti…
  • Statutes amendment
  • Power of attorney, Rony LEBOTTE
08-02
State Gazette act Restructuring
Permanent representative: Jan Peeters · Power of attorney · Merger7 facts ▸
  • Board meeting, 16-01-2013
  • Power of attorney, Jan Peeters NV
  • Power of attorney, Jan Peeters NV
  • Permanent representative, Jan Peeters
  • Merger
  • Accounting effect, 01-01-2013
  • Purpose change, De vennootschap heeft tot doel: De handel, de import en export van chemische, pharmaceutische, parapharmaceutische, phytopharmaceutische producten, pharmaceutis…
2012
12-07
State Gazette act Capital & shares
Statutes amendment2 facts ▸
  • General meeting, 11-06-2012
  • Statutes amendment
2010
22-09
State Gazette act Appointment: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
Permanent representative: Peter Opsomer3 facts ▸
  • General meeting, 15-06-2010
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Peter Opsomer
2008
01-09
State Gazette act Resignation: Jessie Lison (day-to-day manager)
Appointment: Ronny Lebotte (day-to-day manager) · Appointment condition4 facts ▸
  • Board meeting, 14-07-2008
  • Director resignation, Jessie Lison (day-to-day manager)
  • Director appointment, Ronny Lebotte (day-to-day manager)
  • Appointment condition, dagelijks bestuur, 1.000.000 EUR
2007
04-07
State Gazette act Appointment: PricewaterhouseCoopers Bedrijfsrevisoren bcvba (statutory auditor)
2 facts ▸
  • General meeting, 18-06-2007
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren bcvba (statutory auditor)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
32 of 32 acts read

Directors · office · real estate

Directors
10 directors, no change since 2025
Lien Winne BV
Statutory auditor · since 06-10-2025 · Legal entity · perm. rep.: Lien Winne
Current
Humalix
Day-to-day manager · since 16-06-2023 · Private limited company · perm. rep.: CAVEYE Celine
Current
PADILLA PAPACEIT Rafael
Director · since 16-06-2023
Current
Cornelia de Jong
Director · since 04-12-2017
Current
Peter De Sutter
Day-to-day manager · since 01-09-2019
Not recently confirmed
Humalix bvba
Day-to-day manager · since 25-03-2019 · Legal entity
Not recently confirmed
4 other directors
Rafael Padilla
Director · since 04-12-2017
Not recently confirmed
Corrielia de Jong
Director · since 01-01-2017
Not recently confirmed
JAN PEETERS
Director · since 18-06-2013 · Public limited company · perm. rep.: Jan Peeters
Not recently confirmed
Ronny Lebotte
Day-to-day manager · since 14-07-2008
Not recently confirmed
06-10-2025 Lien Winne BV: Appointed as Statutory auditor
16-06-2023 Humalix: Mandate renewed as Day-to-day manager
16-06-2023 PADILLA PAPACEIT Rafael: Mandate renewed as Director
16-06-2023 Cornelia de Jong: Mandate renewed as Director
11-05-2021 Hernando Acosta: Resigned as Day-to-day manager
Full history in the Timeline (32 changes) →
Location & real-estate footprint
Registered office, Nazareth-De Pinte · 1 establishment unit since 2001
seat establishment The establishment unit on the map
Ground area
1.6 ha
Building footprint
7,285 m²
Volume, LiDAR
70,207 m³
Parcel 44048A0094/00L000, Flanders · tallest building 21.6 m, ±2 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
FAGRON BELGIUM
Venecoweg 20A, 9810 Nazareth-De PinteAir transport
since 20012.005.946.241
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44048A0094/00L000 Flanders 1.6 ha 1 · 7,284 m² 21.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Deloitte Bedrijfsrevisoren/Réviseurs d’EntreprisesCurrent
Statutory auditor · represented by Ine Nuyts
17-06-2019 → present
Show 1 earlier auditors
PricewaterhouseCoopers Reviseurs d'Entreprises
Statutory auditor
succeeded by Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises in 2019
18-06-2007 → 17-06-2019

Articles of association

Purpose
De handel, de import en export van chemische, pharmaceutische, parapharmaceutische, phytopharmaceutische producten, pharmaceutische en medicinale planten en extracten, aroma’s…
Full purpose

De handel, de import en export van chemische, pharmaceutische, parapharmaceutische, phytopharmaceutische producten, pharmaceutische en medicinale planten en extracten, aroma’s, kruiden en geneesmiddelen, de behandeling en de verkoop, in de meest uitgebreide zin, van deze producten, de handel en de vervaardiging van alle toestellen en hun onderdelen en aanhorigheden, alsook alle toebehoren, in de meest ruime zin, voor apotheken, laboratoria en medische installaties in het algemeen, zonder dat deze opsomming enige beperking meebrengt. De vervaardiging, de groot- en de kleinhandel onder al zijn vormen (de aankoop, de verkoop, de import en de export, de vertegenwoordiging, de makelarij, de commissiehandel) van alle pharmaceutische, parapharmaceutische en chemische producten, alsook alle goederen en koopwaren die gebruikelijk verkocht worden door apothekers, drogisten, industrieën, natuurwinkels, schoonheidsspecialisten en kappers. De verwezenlijking van alle drukwerken, zowel voor eigen rekening als voor rekening van derden. De vennootschap zal alle roerende en onroerende goederen, materialen en installaties mogen aankopen, huren, verhuren, bouwen, verkopen of ruilen. De vennootschap zal bekwaam zijn om alle handelingen zonder uitzondering te stellen, die nodig, nuttig of zelfs slechts voordelig hiertoe zijn; zij zal zelfs mogen deelnemen aan de activiteiten van andere vennootschappen met een identiek, gelijkaardig of analoog voorwerp en dit via inbreng, fusie of om het even hoe. De vennootschap mag eveneens de functie van bestuurder of vereffenaar van andere vennootschappen uitoefenen.

Structure & network

Connections & network

10 connected companies

Acquisitions and mergers

1 transaction
Took over:PHARMAFLORE
BE 0422.946.130merger by absorption · State Gazette act of 29-04-2013 (2 acts)

Capital and shareholders

Capital over the years
  1. 02-01-2026 Capital increase of 3,000,000 EUR · to 3,300,471.74 EUR · in cash
  2. 30-11-2023 Capital stated in the act · 300,471.74 EUR · 20,050 shares

Public money · subsidies and aid

Flemish government

2023 to 2025 · 4 entries · 10,275 EUR awarded · 10,275 EUR paid
Year Entries awardedpaid
2025 2 1,623 EUR1,623 EUR
2024 1 6,948 EUR6,948 EUR
2023 1 1,704 EUR1,704 EUR
Schemes
Werkbaarheidscheque (stopgezet)
1 entry · 6,948 EUR · 6,948 EUR paid · Departement Werk en Sociale Economie
Vlaams opleidingsverlof (VOV)
1 entry · 1,704 EUR · 1,704 EUR paid · Departement Werk en Sociale Economie
Individueel Maatwerk
1 entry · 1,014 EUR · 1,014 EUR paid · Departement Werk, Economie, Wetenschap, Innovatie en Sociale Economie
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 609 EUR · 609 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

1 site
Nazareth-De Pinte2.005.946.241
2 permissions
Groothandelaar grondstoffen · since 01-06-2023
Groothandelaar LM>3 maand · since 14-02-2022

Similar companies · same sector, comparable size

Of 1,897 companies in sector 46460 we hold annual accounts for 1,116. 720 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded05-05-1959
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
46450Wholesale of perfume and cosmetics
Sources
Crossroads Bank for EnterprisesBelgian Official Gazette · 32 actsNational Bank · 49 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.